Clinical Trials Directory

Trials / Completed

CompletedNCT00207493

The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
494 (planned)
Sponsor
Centers for Disease Control and Prevention · Federal
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

Patients diagnosed with chlamydial infections (a sexually transmitted disease) are asked to notify their sex partners and tell them to seek medical evaluation. This project tests an enhancement to the materials provided to patients to help convince their partners to seek evaluation against the standard of care, which is a brief notification instruction. The desired outcomes are greater levels of notification by participants of their partners and lower levels of reinfection among participants.

Detailed description

Patients diagnosed with chlamydial infections (a sexually transmitted disease) are asked to notify their sex partners and tell them to seek medical evaluation: patient referral. Rates of actual referral by patients are unknown, but estimates derived from several evaluations suggest somewhere between 30 - 55% of partners are notified and tested (for chlamydia). Current prevalence and yearly rates of infection suggest this level of partner notification and treatment is insufficient to control the disease. As a program, this project has disseminated notification activities to community health centers that see chlamydial infections, all under the aegis of the awardee (Boston Medical Center). Diagnosis and partner notification can be recorded remotely , but centrally accessed through a secure database. To enhance patient referral effectiveness, this project tests brief instructions to refer (standard of care) against a "kit" containing a specific notification of exposure to chlamydia, an accurate health message about the nature and prognosis of the infection (treated and untreated), options for seeking free or low-cost evaluation and treatment, and a satisfaction survey. A second, crossed condition is pure patient referral against a contract (72 hours to notify, after which study staff will refer cases to public health professionals for notification). Principal outcomes measured are levels of notification by participants of their partners and levels of reinfection among participants. We also measure psychosocial mediating effects, as well as potential unintended consequences of patient referral: incident partner violence against prevalent (baseline rates) violence, depressed affect

Conditions

Interventions

TypeNameDescription
BEHAVIORALKit enhancement to referral
PROCEDUREpatient referral versus contract referral

Timeline

Start date
2000-10-01
Primary completion
2005-09-01
Completion
2007-09-01
First posted
2005-09-21
Last updated
2012-09-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00207493. Inclusion in this directory is not an endorsement.